kabutan

TAKARA BIO INC.(4974) Summary

4974
TSE Prime
TAKARA BIO INC.
791
JPY
-2
(-0.25%)
Dec 5, 12:46 pm JST
5.09
USD
Dec 4, 10:46 pm EST
Result
PTS
outside of trading hours
790.8
Dec 5, 12:41 pm JST
Summary Chart Historical News Financial Result
PER
PBR
0.93
Yield
ー%
Margin Trading Ratio
10.32
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
791 JPY 5.09 USD
Previous Close Dec 4
793 JPY 5.10 USD
High Dec 5, 9:24 am
793 JPY 5.11 USD
Low Dec 5, 9:04 am
788 JPY 5.07 USD
Volume
111,600
Trading Value
0.09B JPY 0.57M USD
VWAP
790.62 JPY 5.1 USD
Minimum Trading Value
79,100 JPY 509 USD
Market Cap
0.10T JPY 0.61B USD
Number of Trades
191
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly High
1-Year Average
568
1-Year High Aug 21, 2025
6,306
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 213,300 532,000 2.49
Nov 21, 2025 212,400 571,300 2.69
Nov 14, 2025 192,900 557,700 2.89
Nov 7, 2025 108,700 559,000 5.14
Oct 31, 2025 110,100 555,500 5.05
Company Profile
TAKARA BIO INC. is a leading supplier of reagents and equipment for genetic research, with a strong focus on iPS cells and regenerative medicine. The company also offers contract services.
Sector
Chemicals
TAKARA BIO INC. operates businesses based on biotechnology, utilizing genetic engineering and cell engineering technologies. In its core reagents and equipment business, the company provides products and services for gene and cell analysis. In the contract business, TAKARA BIO INC. offers CDMO services including genetic analysis, testing, and regenerative medicine product-related contract services. In the gene therapy business, the company develops, manufactures, and sells manufacturing aids used in gene therapy drug production, and is advancing clinical development of gene therapy drugs using proprietary technologies.